uniQure N.V. Stock Issued During Period, Shares, New Issues
uniQure N.V. (QURE) had Stock Issued During Period, Shares, New Issues of 733.70 thousand shares as of 2019-09-13, per its 10-K filed 2022-02-25.
Discontinued › Shareholders' Equity
us-gaap:StockIssuedDuringPeriodSharesNewIssues · last filed 2022-02-25
- 2019-09-13: Stock Issued During Period, Shares, New Issues 733.70K shares.
- 2019-09-10: Stock Issued During Period, Shares, New Issues 4.89M shares.
- 2018-05-07: Stock Issued During Period, Shares, New Issues 5.17M shares.
- 2017-10-27: Stock Issued During Period, Shares, New Issues 5.00M shares.
| Period end | Stock Issued During Period, Shares, New Issues |
|---|---|
| 2019-09-13 | 733.70K shares 10-K · filed 2022-02-25 |
| 2019-09-10 | 4.89M shares 10-K · filed 2022-02-25 |
| 2018-05-07 | 5.17M shares 10-K · filed 2021-03-01 |
| 2017-10-27 | 5.00M shares 10-K · filed 2020-03-02 |
| 2015-04-15 | 3.00M shares 10-K · filed 2018-03-14 |
| 2014-02-05 | 5.40M shares 10-K · filed 2017-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SELLAS Life Sciences Group, Inc. (SLS) | United States | $2.420B | -91.87 |
| Vera Therapeutics, Inc. (VERA) | United States | $2.402B | -7.67 |
| Harmony Biosciences Holdings, Inc. (HRMY) | United States | $2.399B | 11.67 |
| Nurix Therapeutics, Inc. (NRIX) | United States | $2.457B | -5.39 |
| Mineralys Therapeutics, Inc. (MLYS) | United States | $2.353B | -6.82 |
| Viridian Therapeutics, Inc.\DE (VRDN) | United States | $2.342B | -5.38 |
| SUPERNUS PHARMACEUTICALS, INC. (SUPN) | United States | $2.517B | -24.63 |
| Immunome Inc. (IMNM) | United States | $2.538B | -9.45 |
| Disc Medicine, Inc. (IRON) | United States | $2.553B | -11.40 |
| Zai Lab Ltd (ZLAB) | $2.241B | -113.34 |